BioCryst Pharmaceuticals, Inc. (BCRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.64B |
| Enterprise Value | 1.99B |
| P/E Ratio | -5.64 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 2.19 |
| Price/Book Ratio | -4.55 |
| Enterprise/Revenue | 2.47 |
| Enterprise/EBITDA | -7.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.41 |
| Operating Margin | -0.33 |
AD
Management Effectiveness
| Return On Assets | -0.69 |
| Return On Equity | 1.02 |
Income Statement
| Revenue | 874.84M |
| Revenue/Share | 3.7 |
| Gross Profit | 855.76M |
| EBITDA | 347.65M |
| Net Income | 263.86M |
| Diluted EPS | 1.21 |
Balance Sheet
| Total Cash | 352.57M |
| Total Cash/Share | 1.39 |
| Total Debt | 409.86M |
| Total Debt/Equity | -0.9 |
| Current Ratio | 2.32 |
| Book Value Per Share | -1.79 |
Price History
| 52-Week Change | 0.62 |
| 52-Week High | 11.22 |
| 52-Week Low | 6 |
| Moving Average 50 Days | 9.68 |
| Moving Average 200 Days | 8.6 |
Statistics
| Average Volume | 4.45M |
| Shares Outstanding | 254.16M |
| % Held by Institutions | 103.72 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
